News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Al-Ola Abdallah: Cross-Collaboration is Key for Cellular Therapies Options Across Cancer Types
Al-Ola Abdallah and Zahra Mahmoudjafari
Aug 9, 2025, 15:05

Al-Ola Abdallah: Cross-Collaboration is Key for Cellular Therapies Options Across Cancer Types

Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:

“Cross-Collaboration is Key for Cellular Therapies Options Across Cancer Types

‎The 2025 National ⁦‪ICE_T‬⁩ Symposium gave oncology experts an opportunity to share ideas regarding the administration of cellular therapies. Zahra Mahmoudjafari, spoke with ⁦‪CancerNetwork‬⁩.”

More posts featuring Cellular Therapies.

2025 National ⁦‪ICE_T‬⁩ Symposium Al-Ola Abdallah cancer CancerNetwork‬⁩ Cellular Therapy OncoDaily Oncology Zahra Mahmoudjafari
Special Coverage
Voices
Aug 9, 2025, 15:05
Al-Ola Abdallah: Cross-Collaboration is Key for Cellular Therapies Options Across Cancer Types
Voices
Aug 9, 2025, 14:56
Are You Passionate About Patient Involvement in Cancer Research? - EORTC
Voices
Aug 9, 2025, 14:53
Aravind Palraj: Immune-Related Adverse Events Can Mimic Cancer Flare
Voices
Aug 9, 2025, 14:51
4 Days to Go Until the NSW Cancer Summit 2025 - Cancer Institute NSW
Societies
Aug 9, 2025, 13:59
AACR Project GENIE 18.0: Genomic Insights from 7,900+ Sarcoma and Bone Cancer Patients
Voices
Aug 9, 2025, 13:48
Nicola Normanno joins "From Policy to Practice" - EAPM
Oncolibrary
Aug 9, 2025, 12:50
FDA Grants Accelerated Approval to Zongertinib for HER2 TKD Mutated Non-Squamous NSCLC
Science
Aug 9, 2025, 12:08
Amol Akhade: Zongertinib - A New Targeted Therapy Option for a Rare Molecular Subset of Lung Cancer
Science
Aug 9, 2025, 12:07
UCLA Study Finds: Mailed At-Home Kits Boost Colorectal Cancer Screening for Ages 45–49
Voices
Aug 9, 2025, 11:59
Al-Ola Abdallah: MRD Negativity Isn’t the Finish Line
Science
Aug 9, 2025, 11:44
Sylvester Researchers Uncover Molecular Drivers of Cellular Differentiation
Voices
Aug 9, 2025, 11:37
Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders